Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide effects on appetite and ghrelin in Prader-Willi syndrome
2010-023179-25Phase 2Unknown
- Sponsor
- Aintree University Hospital
- Start
- Jul 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of exenatide in Prader-Willi syndrome (PWS) (3 arms), sponsored by Aintree University Hospital. Primary endpoints: Change in circulating ghrelin levels, Change in ghrelin isoforms and 2 more. Status: unknown.
02
Drugs
exenatide
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on 2010-023179-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023179-25.